who's who

3 Houston innovators to know this week

This week's innovators to know include Samantha Snabes and Charlotte Craff of Re:3D and Andrew Bruce of Data Gumbo. Photos courtesy

Editor's note: In today's Monday roundup of Houston innovators to know as we start a new week, we introduce you to two forward-thinking 3D printing experts and a startup founder with fresh funds to tackle smart contracts in the industrial sector.

Samantha Snabes and Charlotte Craff of Re:3D

Re:3D's Samantha Snabes, co-founder, and Charlotte Craff, who oversees community relations, join the Houston Innovators Podcast to share what makes their company different and where the industry is headed. Photos courtesy of Re:3D

Houston-based Re:3D has no shortage of exciting business opportunities — from developing bigger and better 3D printers to hosting tours in their lab. But, one thing co-founder Samantha Snabes and community expert Charlotte Craff are proud of is their partnership with local organizations to create PPE for the People, a movement that helped create and provide PPE for workers in need.

"As the pandemic continued, the data was emerging that people of color in Black and Brown communities and underserved communities were at greater risk of critical illness from COVID-19," Craff says on the podcast. "We wanted to specifically target people of color who were working as Texas opened back up its doors." Read more.

Andrew Bruce, CEO of Data Gumbo

Andrew bruce's growing Houston blockchain startup has raised $4 million to go toward supporting sales. Photo courtesy of Data Gumbo

While the intersection of dropping oil prices earlier this year and a global pandemic provided its own set of challenges, one thing Andrew Bruce of Data Gumbo Corp. observed is that it was more important than ever for the energy industry to focus on their bottom line. And that's exactly what his technology allows to happen.

"The opportunity in all this is companies have got to cut expenses," Andrew Bruce, CEO and founder, tells InnovationMap. "What's happened to us is our sales have absolutely exploded — in a good way. We have a huge number of leads, and we have to be able to deliver on those leads."

Last month, Data Gumbo closed a $4 million series B funding round led by new investor L37, which has operations in the Bay Area and in Houston. The round also saw contribution from returning investors Equinor Ventures and Saudi Aramco Energy Venture. Read more.

Trending News

Building Houston

 
 

Dr. Peter Hotez and Dr. Maria Elena Bottazzi have been recognized by Fast Company for their leadership in developing low-cost COVID vaccine. Photo courtesy of Texas Children's

This week, Fast Company announced its 14th annual list of Most Creative People in Business — and two notable Houstonians made the cut.

Dr. Peter Hotez and his fellow dean of the National School of Tropical Medicine at Baylor College of Medicine, Dr. Maria Elena Bottazzi, were named among the list for “open sourcing a COVID-19 Vaccine for the rest of the world.” The list, which recognizes individuals making a cultural impact via bold achievements in their field, is made up of influential leaders in business.

Hotez and Bottazzi are also co-directors for the Texas Children's Hospital's Center for Vaccine Development -one of the most cutting-edge vaccine development centers in the world. For the past two decades it has acquired an international reputation as a non-profit Product Development Partnership (PDP), advancing vaccines for poverty-related neglected tropical diseases (NTDs) and emerging infectious diseases of pandemic importance. One of their most notable achievements is the development of a vaccine technology leading to CORBEVAX, a traditional, recombinant protein-based COVID-19 vaccine.

"It's an honor to be recognized not only for our team's scientific efforts to develop and test low cost-effective vaccines for global health, but also for innovation in sustainable financing that goes beyond the traditional pharma business model," says Hotez in a statement.

The technology was created and engineered by Texas Children's Center for Vaccine Development specifically to combat the worldwide problem of vaccine access and availability. Biological E Limited (BE) developed, produced and tested CORBEVAX in India where over 60 million children have been vaccinated so far.

Earlier this year, the doctors were nominated for the 2022 Nobel Peace Prize for their research and vaccine development of the vaccine. Its low cost, ease of production and distribution, safety, and acceptance make it well suited for addressing global vaccine inequity.

"We appreciate the recognition of our efforts to begin the long road to 'decolonize' the vaccine development ecosystem and make it more equitable. We hope that CORBEVAX becomes one of a pipeline of new vaccines developed against many neglected and emerging infections that adversely affect global public health," says Bottazzi in the news release from Texas Children's.

Fast Company editors and writers research candidates for the list throughout the year, scouting every business sector, including technology, medicine, engineering, marketing, entertainment, design, and social good. You can see the complete list here

.

Trending News